GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate

Objective. To analyse seven RA Core Data Set measures and three indices for their capacity to distinguish treatment results in early RA in the GUEPARD treat-to-target clinical trial vs ESPOIR routine care. Methods. Post hoc analyses compared 65 GUEPARD and 130 matched control ESPOIR patients over 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Castrejón, Isabel, Pincus, Theodore, Soubrier, Martin, Lin, Yih Chang, Rat, Anne-Christine, Combe, Bernard, Dougados, Maxime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775294/
https://www.ncbi.nlm.nih.gov/pubmed/23864169
http://dx.doi.org/10.1093/rheumatology/ket230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775294/
https://www.ncbi.nlm.nih.gov/pubmed/23864169
http://dx.doi.org/10.1093/rheumatology/ket230

Ejemplares similares